Mr Matthew Shiels > Kirkland & Ellis LLP > New York, United States > Lawyer Profile
Kirkland & Ellis LLP Offices
601 LEXINGTON AVENUE
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Mr Matthew Shiels
Work Department
Executive Compensation
Position
Matthew T. Shiels is a partner in the Firm’s Executive Compensation Group. Matt regularly advises private and public companies, private equity funds, senior executives and portfolio managers in connection with executive compensation and employee benefits in a number of complex corporate transactions, including mergers and acquisitions and other business transactions. Matt’s practice focuses on providing advice on a wide variety of executive compensation matters, including structuring and implementing deferred compensation, equity compensation, bonus compensation and incentive compensation plans and agreements. Matt’s practice also includes drafting transactional documents, including employment, consulting, termination, change-in-control, severance and release agreements, as well as identifying issues arising under, and assisting in complying with, the Internal Revenue Code (including sections 280G and 409A), federal securities laws, applicable exchange regulations and related corporate governance rules. He also has experience with qualified plans, individual retirement accounts, wage laws, penalty assessment (by the Department of Labor and Internal Revenue Service), treatment of benefit plans in bankruptcy and complex ERISA issues involving fiduciary duties and prohibited transactions.
Education
LL.M., New York University School of Law; J.D., Benjamin N. Cardozo School of Law, B.S., cum laude, State University of New York at Albany, B.S.
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Government > Government relations
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Intellectual property > Patents: litigation (full coverage)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Environment > Environment: litigation
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Government > State attorneys general
- Finance > Structured finance: securitization
- Tax > US taxes: contentious
- Dispute resolution > E-discovery
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Energy > Energy regulation: oil and gas
- Dispute resolution > Leading trial lawyers
- Healthcare > Life sciences
- Media, technology and telecoms > Media and entertainment: transactional
- Real estate > Construction (including construction litigation)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Investment fund formation and management > Mutual/registered/exchange-traded funds